{"slideshow_credits": null, "snippet": "Irish takeover laws allow the pharmaceutical company Elan to lobby its shareholders indirectly against Royalty Pharma\u2019s $6.4 billion hostile bid.", "abstract": "Irish takeover laws allow the pharmaceutical company Elan to lobby its shareholders indirectly against Royalty Pharma\u2019s $6.4 billion hostile bid.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Steven", "role": "reported", "rank": 1, "organization": ""}], "original": "By STEVEN M. DAVIDOFF"}, "web_url": "http://dealbook.nytimes.com/2013/06/06/elan-finds-creative-poison-pill-to-defend-against-a-hostile-bid/", "lead_paragraph": null, "headline": {"main": "Elan Finds Creative 'Poison Pill' to Defend Against a Hostile Bid", "kicker": "DealBook"}, "_id": "51b0f0c040e9ec65d203bb7c", "word_count": "1594", "multimedia": [], "pub_date": "2013-06-06T16:22:09Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "glocations", "value": "Ireland", "rank": "1"}, {"name": "organizations", "value": "Elan Corporation PLC", "rank": "1"}, {"name": "organizations", "value": "Royalty Pharma", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}